Olivier Govaere

Dr. Olivier Govaere

Role: Research Associate Email: olivier.govaere@newcastle.ac.uk

About

Dr. Olivier Govaere is a Research Associate based at the Institute of Cellular Medicine, Newcastle University. He obtained his Masters Degree in Biomedical Sciences at the KU Leuven, Belgium.

In 2008 he joined the lab of Prof Tania Roskams to do a PhD focusing on the role of hepatic progenitor cells in liver regeneration and carcinogenesis. He continued this during a 3-year postdoctoral fellowship investigating phenotype switching in human hepatocellular carcinomas and characterisation of the human hepatic progenitor cell niche in chronic liver disease.

Dr. Govaere joined the Newcastle liver group to work on the EPOS project (Elucidating Pathways of Steatohepatitis) under the supervision of Dr Fiona Oakley, Dr Quentin M. Anstee and Prof Ann Daly.

Education

  • BSc, KULeuven, Belgium (2006)
  • MSc, KULeuven, Belgium (2008)
  • PhD in Molecular and Stem Cell Medicine, KU Leuven, Belgium (2012)
  • Certificate in ‘Knowledge & technology transfer and the exploitation of research’, KU Leuven Research & Development (2014)

Memberships

  • Belgian Association for Study of the Liver (BASL)
  • Young Belgian Association for Study of the Liver (yBASL, co-founder)
  • European Association for the Study of the Liver (EASL)

Invited Lectures & Meetings

  • Annual meeting of the European Association for the Study of the Liver (EASL), Barcelona, Spain, 2012 Keratin19: A Key Role Player in the Invasion of Human Hepatocellular Carcinomas with Progenitor Cell Features.
  • Annual meeting of the European Association for the Study of the Liver (EASL), Amsterdam, 2013 EASL - Young Investigator’s Seminar: IS CELL THERAPY THE FUTURE FOR LIVER DISEASE TREATMENT?
  • ICR-Lecture Series. Institute of Cancer Research, Medical University Vienna, Austria. 2013. Hepatic progenitor cells and their role in cancer.
  • EASL HCC Summit Geneva, Switzerland, 2014 Side Population analysis identifies a role for laminin in modulating the human hepatic cancer stem cell niche.
  • Belgian Week of Gastroenterology, Brussels, Belgium, 2015 Young BASL. Lab introduction: Translational Cell and Tissue Research, Department of Imaging & Pathology.
  • Annual meeting of the European Association for the Study of the Liver (EASL), Vienna, Austria, 2015 High-throughput sequencing of the human hepatic progenitor cell niche reveals different signalling pathways depending on the underlying chronic liver disease.

Awards

  • Award for Best Clinical Presentation, Belgian Week of Gastroenterology, 2011
  • Award for Best Abstract, 6th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 2011
  • F1000Prime. Faculty of 1000 Recommendation for ‘Keratin 19: a key role player in the invasion of human hepatocellular carcinomas. Gut, 2013 (DOI: 10.3410/f.718078724.793486745)’
  • Young Investigator Top 10% award, EASL, London, 2014. Abstract “Side Population analysis identifies a role for laminin in modulating the human hepatic cancer stem cell niche.”
  • MSD award Best Clinical Publication: ‘Keratin19: A Key Role Player in the Invasion of Human Hepatocellular Carcinomas’. BASL Winter Meeting, La Hulpe, Belgium 2014.
  • EASL Young Investigator Bursary, Annual meeting of the European Association for the Study of the Liver 2011, 2012, 2013, 2014 and 2015.
  • Inter-university initiative within the ‘Framework for Young Researchers’ (OJO) from the Flemish government, to finance the ‘young BASL School of Hepatology 2015’.